BioNTech’s Innovation Series R&D Day BioNTech leadership ... ii Kim HJ, et al. Arch Pharm Res. 2022;45(6):401-416.

A Winchester man who participated in a multi-state drug trafficking operation will be released from prison later this month ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Both Moderna and Pfizer-BioNTech manufacture the COVID vaccine in lower doses ... A Kaiser Family Foundation survey from 2022 ...

Moderna's Spikevax COVID vaccine brought in sales of $1.8 billion, up 3.5% over the previous year and handily beating analysts' average expectations of $1.38 billion. The company said it benefited ...

Despite the potential in oncology, BNTX's current valuation is high relative to its non-COVID revenue prospects, warranting a ...

In a related JAMA Viewpoint, the authors noted that COVID-19 peaked in 2020 and 2021 as the third highest cause of mortality ...

Regarding the 2024-2025 Pfizer-BioNTech COVID-19 vaccine ... The lawmaker has served in the Senate since 2011 and was most ...

Antiviral Immunoglobulin Market. The global antiviral immunoglobulin market was valued at USD 4.6 billion in 2022 and is ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

Pfizer-BioNTech: The Pfizer-BioNTech vaccine was ... the Moderna vaccine full approval for people 18 and older in January 2022. People ages 6 months and older are eligible to receive the Moderna ...

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe ...